 |
|
Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men
A Prospective Cohort Study
Leo K. Niskanen, MD, PhD;
David E. Laaksonen, MD, PhD, MPH;
Kristiina Nyyssönen, PhD;
Georg Alfthan, PhD;
Hanna-Maaria Lakka, MD, PhD;
Timo A. Lakka, MD, PhD;
Jukka T. Salonen, MD, PhD
Arch Intern Med. 2004;164:1546-1551.
Background Despite abundant epidemiologic evidence, the role of elevated serum uric acid level as a cardiovascular risk factor is controversial. We assessed the predictive value of serum uric acid levels for cardiovascular and overall mortality.
Methods A population-based prospective cohort study was performed of 1423 middle-aged Finnish men initially without cardiovascular disease, cancer, or diabetes. The main outcome measure was death from cardiovascular disease and any cause.
Results The mean follow-up was 11.9 years. There were 157 deaths during follow-up, of which 55 were cardiovascular. In age-adjusted analyses, serum uric acid levels in the upper third were associated with a greater than 2.5-fold higher risk of death from cardiovascular disease than levels in the lower third. Taking into account cardiovascular risk factors and variables commonly associated with gout increased the relative risk to 3.73. Further adjustment for factors related to the metabolic syndrome strengthened the risk to 4.77. Excluding the 53 men using diuretics did not alter the results. In age-adjusted analyses, men with serum uric acid levels in the upper third were 1.7-fold more likely to die of any cause than men with levels in the lower third. Adjustment for further risk factors strengthened the association somewhat.
Conclusions Serum uric acid levels are a strong predictor of cardiovascular disease mortality in healthy middle-aged men, independent of variables commonly associated with gout or the metabolic syndrome. Serum uric acid measurement is an easily available and inexpensive risk marker, but whether its relationship to cardiovascular events is circumstantial or causal remains to be answered.
From the Department of Medicine, Kuopio University Hospital, Kuopio, Finland (Drs Niskanen and Laaksonen); Research Institute of Public Health, Kuopio (Drs Nyyssönen and Salonen); Biomarker Laboratory, Department of Health and Functional Capacity, National Public Health Institute, Helsinki, Finland (Dr Alfthan); Pennington Biomedical Research Center, Louisiana State University, Baton Rouge (Drs H.-M. Lakka and T. A. Lakka); Department of Public Health and General Practice, University of Kuopio (Drs H.-M. Lakka and Salonen); and Inner Savo Health Center, Suonenjoki, Finland (Dr Salonen). The authors have no relevant financial interest in this article.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin
Luque-Ramirez et al.
Hum Reprod 2008;23:1594-1601.
ABSTRACT
| FULL TEXT
Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General Population: The MONICA/KORA Cohort Study
Meisinger et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1186-1192.
ABSTRACT
| FULL TEXT
RE: "PLASMA URATE AND RISK OF PARKINSON'S DISEASE"
Wise et al.
Am J Epidemiol 2008;167:752-753.
FULL TEXT
Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men
Strasak et al.
Clin. Chem. 2008;54:273-284.
ABSTRACT
| FULL TEXT
The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women
Strasak et al.
Ann Oncol 2007;18:1893-1897.
ABSTRACT
| FULL TEXT
Podagra, Uric Acid, and Cardiovascular Disease
Alderman
Circulation 2007;116:880-883.
FULL TEXT
Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease
Choi and Curhan
Circulation 2007;116:894-900.
ABSTRACT
| FULL TEXT
Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents
Ford et al.
Circulation 2007;115:2526-2532.
ABSTRACT
| FULL TEXT
Angiotensin II Induces Endothelial Xanthine Oxidase Activation: Role for Endothelial Dysfunction in Patients With Coronary Disease
Landmesser et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:943-948.
ABSTRACT
| FULL TEXT
Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk
Grundy
Arterioscler. Thromb. Vasc. Bio. 2007;27:4-7.
FULL TEXT
Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers
Howard-Alpe et al.
Br J Anaesth 2006;97:758-769.
ABSTRACT
| FULL TEXT
Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study
Bos et al.
Stroke 2006;37:1503-1507.
ABSTRACT
| FULL TEXT
Uric acid and inflammatory markers
Ruggiero et al.
Eur Heart J 2006;27:1174-1181.
ABSTRACT
| FULL TEXT
Serum Uric Acid Is Associated With Microalbuminuria in Prehypertension
Lee et al.
Hypertension 2006;47:962-967.
ABSTRACT
| FULL TEXT
Uric Acid, Left Ventricular Mass Index, and Risk of Cardiovascular Disease in Essential Hypertension
Iwashima et al.
Hypertension 2006;47:195-202.
ABSTRACT
| FULL TEXT
Measures of Oxidized Low-Density Lipoprotein and Oxidative Stress Are Not Related and Not Elevated in Otherwise Healthy Men With the Metabolic Syndrome
Sjogren et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:2580-2586.
ABSTRACT
| FULL TEXT
Diagnosis and management of gout: a rational approach
Suresh
Postgrad. Med. J. 2005;81:572-579.
ABSTRACT
| FULL TEXT
Confounders of Uric Acid Levels
Kuo and Yang
Arch Intern Med 2005;165:1071-1071.
FULL TEXT
Serum Uric Acid and Target Organ Damage in Primary Hypertension
Viazzi et al.
Hypertension 2005;45:991-996.
ABSTRACT
| FULL TEXT
Uric Acid Validated as a Risk Factor for Heart Disease
JWatch Emergency Med. 2004;2004:6-6.
FULL TEXT
|
